Statin use after acute myocardial infarction: a nationwide study in Denmark
Open Access
- 6 May 2005
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 60 (2) , 150-158
- https://doi.org/10.1111/j.1365-2125.2005.02408.x
Abstract
Aims To study outpatient statin use after first acute myocardial infarction (AMI) in Denmark between 1995 and 2002 and to determine the predictors of statin use. Methods This is a nationwide population‐based study using administrative registries. Patients with first AMI between 1995 and 2002 older than 30 years of age and alive 6 months after discharge (n = 45 219) were identified through the National Patient Registry. The statins purchased by these patients within 6 months after discharge were determined using the Registry of Medicinal Product Statistics, a nationwide prescription database. Results Statin use following AMI increased from 13% in 1995 to 61% in 2002. In 2002, 81% of patients aged 30–64 years used statins. Older patients used fewer statins, but use increased more among patients aged 75–84 years: from 1.3% to 43%. Use in elderly patients did not differ according to gender in 2000–02, but young men used more than younger women. In 2000–02, patients with diabetes (odds ratio (OR): 0.84; 95% confidence interval (CI): 0.74–0.95) and with heart failure (OR: 0.70; 95% CI: 0.64–0.76) were undertreated; this trend was present throughout the period. Conclusions In this nationwide study, younger patients after AMI had high statin use in 2002, but high‐risk patients such as those with diabetes and heart failure were still being undertreated.Keywords
This publication has 37 references indexed in Scilit:
- Does it matter what a hospital is “high volume” for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative dataBMJ, 2004
- The validity of the diagnosis of acute myocardial infarction in routine statistics A comparison of mortality and hospital discharge data with the Danish MONICA registryJournal of Clinical Epidemiology, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?Heart, 2002
- Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age)Circulation, 2002
- Use of lipid‐lowering drugs during 1991–98 in Northern Jutland, DenmarkBritish Journal of Clinical Pharmacology, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Clinical Characteristics and Mortality of Patients Screened for Entry Into the Trandolapril Cardiac Evaluation (TRACE) StudyThe American Journal of Cardiology, 1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Inhalation of levomepromazine in severe acute asthmaThe Lancet, 1994